IMGATUZUMAB
UNII V77J4WJF9Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Imgatuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V77J4WJF9Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 959963-46-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
V77J4WJF9Z
CAS Registry Number
959963-46-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IMGATUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9598
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
ZZ-142
Identifier assigned by the United States Adopted Names Council.
Substance Type
IMGATUZUMAB
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imgatuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IMGATUZUMAB

Common Names & Synonyms

IMGATUZUMAB [USAN]
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, ERBB1, HER1)), HUMANIZED MONOCLONAL ANTIBODY
Imgatuzumab [WHO-DD]
imgatuzumab [INN]

Technical Codes

GA-201
GA201
HUMA-B
HUMAB
RG-7160
RG7160
RO-5083945
RO5083945